Lars Nordholm
individual
About
Lars Nordholm appears to be a Danish pharmaceutical scientist and R&D professional. Public records link him to Novo Nordisk A/S through peer-reviewed publications in pharmacology and growth-hormone-related research, and to NMD Pharma as a named inventor on a 2024 patent application covering treatment methods for myasthenia gravis. No evidence was found that he acts as a fund manager or personal capital deployer.
Areas of interest
biotechpharmaceutical R&Dneurologyneuromuscular disordersgrowth hormonedrug development